Adiponectin and leptin molecular actions and clinical significance in breast cancer
- PMID: 24505549
- PMCID: PMC3913152
Adiponectin and leptin molecular actions and clinical significance in breast cancer
Abstract
Obesity is an important public health problem and major risk factor for postmenopausal breast cancer. Adipose tissue is the major component involved in the control of the metabolism through energy homeostasis, adipocyte differentiation, insulin sensitivity and the activation of anti-inflammatory metabolic and immune pathways. Leptin and Adiponectin pathways are involved in proliferation process in breast cancer. Current review describes potential relationship between the molecular actions and clinical significance of leptin and adiponectin in breast cancer.
Keywords: Adiponectin; Breast Cancer; Cytokine; Leptin; Obesity.
Figures
Similar articles
-
Molecular mechanisms of leptin and adiponectin in breast cancer.Eur J Cancer. 2011 Jan;47(1):33-43. doi: 10.1016/j.ejca.2010.09.005. Eur J Cancer. 2011. PMID: 20889333 Review.
-
Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin.Curr Opin Lipidol. 2002 Feb;13(1):51-9. doi: 10.1097/00041433-200202000-00008. Curr Opin Lipidol. 2002. PMID: 11790963 Review.
-
Obesity and breast cancer: status of leptin and adiponectin in pathological processes.Cancer Metastasis Rev. 2010 Dec;29(4):641-53. doi: 10.1007/s10555-010-9252-1. Cancer Metastasis Rev. 2010. PMID: 20821253 Review.
-
Relationship of adipokine to insulin sensitivity and glycemic regulation in obese women--the effect of body weight reduction by caloric restriction.Vojnosanit Pregl. 2013 Mar;70(3):284-91. doi: 10.2298/vsp1303284v. Vojnosanit Pregl. 2013. PMID: 23607240
-
Leptin and adiponectin: emerging therapeutic targets in breast cancer.J Mammary Gland Biol Neoplasia. 2013 Dec;18(3-4):321-32. doi: 10.1007/s10911-013-9302-8. Epub 2013 Oct 18. J Mammary Gland Biol Neoplasia. 2013. PMID: 24136336 Review.
Cited by
-
LEP (-2548G>A LEP) and LEPR (223Gln>Arg, 109Lys>Arg) polymorphisms as breast cancer risk factors in the Polish female population.Mol Biol Rep. 2021 Apr;48(4):3237-3244. doi: 10.1007/s11033-021-06328-7. Epub 2021 Apr 17. Mol Biol Rep. 2021. PMID: 33864589 Free PMC article.
-
Correlation of leptin receptor expression with BMI in differential grades of human meningiomas.Oncol Lett. 2016 Apr;11(4):2515-2519. doi: 10.3892/ol.2016.4272. Epub 2016 Feb 24. Oncol Lett. 2016. PMID: 27073509 Free PMC article.
-
Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.Front Endocrinol (Lausanne). 2023 Jun 8;14:1148934. doi: 10.3389/fendo.2023.1148934. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37361533 Free PMC article. Review.
-
New Insights Into Adipokines and the Tumor Microenvironment in Breast Cancer.Cancer Control. 2025 Jan-Dec;32:10732748251347917. doi: 10.1177/10732748251347917. Epub 2025 Jun 10. Cancer Control. 2025. PMID: 40494755 Free PMC article. Review.
-
Energy homeostasis genes modify the association between serum concentrations of IGF-1 and IGFBP-3 and breast cancer risk.Sci Rep. 2022 Feb 3;12(1):1837. doi: 10.1038/s41598-022-05496-1. Sci Rep. 2022. PMID: 35115550 Free PMC article.
References
-
- Wozniak SE, Gee LL, Wachtel MS, Frezza EE. “Adipose tissue: the new endocrine organ? A review article”. Digestive Diseases and Sciences. 2009;54:1847–1856. - PubMed
-
- Marti A, Berraondo B, Martinez JA. ‘Obese’ protein slims mice. Scienc. 1995;269:475–476. - PubMed
-
- Gesta S, Tseng YH, Kahn CR. “Developmental origin of fat: tracking obesity to its source”. Cell. 2007;131:242–256. - PubMed
-
- Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue: a regulator of inflammation. Best Practice and Research. Clinical Endocrinology and Metabolism. 2005;19:547–566. - PubMed
-
- Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J BiolChem. 1996;271:10697–703. - PubMed
Publication types
LinkOut - more resources
Full Text Sources